Biomedicina, Biotecnología y Salud Pública
Departamento
![Foto de Biomedicina, Biotecnología y Salud Pública](/img/uploaded/020F4D26794903F2D4DC121E67B6D931.jpg)
![Foto de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas](/img/noimage_org.png)
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (31)
2023
-
Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline
Diabetologia, Vol. 66, Núm. 8, pp. 1557-1575
-
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
Journal of Neuroinflammation, Vol. 20, Núm. 1
2022
-
Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes
Fluids and Barriers of the CNS, Vol. 19, Núm. 1
-
Evolutionary Origin of Insulin-Degrading Enzyme and Its Subcellular Localization and Secretion Mechanism: A Study in Microglial Cells
Cells, Vol. 11, Núm. 2
2021
-
Anti-Inflammatory (M2) Response Is Induced by a sp2-Iminosugar Glycolipid Sulfoxide in Diabetic Retinopathy
Frontiers in Immunology, Vol. 12
-
The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity
Theranostics, Vol. 11, Núm. 14, pp. 6983-7004
2020
-
Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD
FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837
-
Modulation of Glial Responses by Furanocembranolides: Leptolide Diminishes Microglial Inflammation in Vitro and Ameliorates Gliosis In Vivo in a Mouse Model of Obesity and Insulin Resistance
Marine drugs, Vol. 18, Núm. 8
2019
-
Corrigendum to “The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling” [Metab Clin Exp 85 (2018) 59–75](S0026049518300714)(10.1016/j.metabol.2018.03.005)
Metabolism: Clinical and Experimental
-
Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury
DMM Disease Models and Mechanisms, Vol. 12, Núm. 7
2018
-
IGF-1, inflammation and retinal degeneration: A close network
Frontiers in Aging Neuroscience, Vol. 10, Núm. JUL
-
Imbalance between pro-apoptotic and pro-survival factors in human retinal pericytes in diabetic-like conditions
Acta Ophthalmologica, Vol. 96, Núm. 1, pp. e19-e26
-
The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling
Metabolism: Clinical and Experimental, Vol. 85, pp. 59-75
-
The sp2-iminosugar glycolipid 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin (DSO2-ONJ) as selective anti-inflammatory agent by modulation of hemeoxygenase-1 in Bv.2 microglial cells and retinal explants
Food and Chemical Toxicology, Vol. 111, pp. 454-466
-
The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity article
Cell Death and Disease, Vol. 9, Núm. 3
2017
-
A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice
Hepatology, Vol. 65, Núm. 3, pp. 950-968
-
Brown Adipose Tissue Bioenergetics: A New Methodological Approach
Advanced Science, Vol. 4, Núm. 4
-
Modulation of microglia in the retina: new insights into diabetic retinopathy
Acta Diabetologica, Vol. 54, Núm. 6, pp. 527-533
-
Somatostatin protects human retinal pericytes from inflammation mediated by microglia
Experimental Eye Research, Vol. 164, pp. 46-54
-
Targeting inflammation in the retina: A new therapeutic approach in diabetic retinopathy
Anales de la Real Academia Nacional de Farmacia, Vol. 83, Núm. 1, pp. 81-92